8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report: July 19, 2010
(Date of earliest event reported)

IDEX CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	1-10235	36-3555336
(State of	(Commission File Number)	(IRS Employer
Incorporation)		Identification No.)

630 Dundee Road
Northbrook, Illinois 60062
(Address of principal executive offices, including zip code)

(847) 498-7070
(Registrant’s telephone number, including area code)

     Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 – Results of Operations and Financial Condition.

On July 19, 2010, IDEX Corporation (the “Company”) issued a press release announcing financial results for the quarter ended June 30, 2010.

A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Current Report furnished pursuant to Item 2.02 shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. This information shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended.

Item 9.01 – Financial Statements and Exhibits.

(d) Exhibits

99.1 Press release dated July 19, 2010 announcing IDEX Corporation’s quarterly operating results

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

IDEX CORPORATION
By:	/s/ Dominic A. Romeo Dominic A. Romeo
	Vice President and Chief Financial Officer

July 20, 2010

Exhibit Index

Exhibit
Number	Description
99.1	Press release dated July 19, 2010 announcing IDEX Corporation’s quarterly operating results

EX-99.1

EXHIBIT 99.1

IDEX CORPORATION REPORTS SECOND QUARTER 2010 RESULTS;
ADJUSTED EARNINGS PER SHARE OF 50 CENTS

NORTHBROOK, IL, July 19 — IDEX Corporation (NYSE: IEX) today announced second quarter 2010 results.

New orders in the quarter totaled $377 million, up 18 percent compared to the prior-year period. Sales in the quarter totaled $379 million, 13 percent higher than the prior-year period.

Second quarter 2010 operating income, adjusted for $1 million of restructuring related charges, was $64 million and resulted in adjusted operating margin of 16.9 percent, up 200 basis points from the prior year (excluding prior year restructuring related charges) due to volume and improved productivity. Adjusted and reported second quarter operating income includes approximately $2 million of acquisition related costs, primarily related to the previously announced Seals Ltd. acquisition.

Excluding the impact from restructuring related charges, second quarter diluted earnings per share was 50 cents, an increase of 13 cents, or 35 percent, from the second quarter of the previous year (excluding prior year restructuring related charges).

Second Quarter 2010 Highlights

• Orders increased 18 percent compared to the prior year (+17 percent organic, +2 percent acquisition and -1 percent for foreign currency translation).

• Sales increased 13 percent compared to the prior year (+11 percent organic, +3 percent acquisition and -1 percent for foreign currency translation).

• Reported net income of $40 million was $12 million, or 45 percent, higher than the prior year. Excluding restructuring related charges, adjusted net income of $41 million was $11 million, or 37 percent, higher than the prior year (excluding prior year restructuring charges).

• Diluted EPS of $0.49 was 15 cents, or 43 percent, higher than the prior year. Excluding restructuring related charges, adjusted diluted EPS of $0.50 was 13 cents, or 35 percent higher than the prior year (excluding prior year restructuring charges).

• EBITDA of $78 million was 21 percent of sales and covered interest expense by more than 21 times.

• Free cash flow of $60 million represents 150% of net income and was 21% higher than the prior year.

“Our second quarter sales results were outstanding. The Health and Science and Fluid and Metering Technology segments outperformed our expectations and, more importantly, continue to outperform the growth rates in the markets we serve. Our Fire and Safety and Dispensing segments continue to perform as planned. These top line results drove strong profitability and this is reflected in a second quarter operating margin of nearly 17 percent, which is 200 basis points higher than the prior year.

Based on current outlook, our projected third quarter 2010 EPS is in the range of 46 to 48 cents on a fully diluted basis. Third quarter estimates exclude approximately $3 million of restructuring related costs associated with the closure of a Health and Science Technologies site in Denmark. Our outlook for the full year 2010 has improved from previous estimates; we expect organic revenue growth in the high single digit range which will result in diluted EPS of $1.85 to $1.90, excluding restructuring related charges.”

Lawrence D. Kingsley
Chairman and Chief Executive Officer

Second Quarter 2010 Business Highlights (excluding restructuring related charges)

Fluid & Metering Technologies

• Sales in the second quarter of $175 million reflected an 11 percent increase compared to the second quarter of 2009 (+12 percent organic and -1 percent for foreign currency translation).

• Operating margin of 17.6 percent represented a 220 basis point improvement compared with the second quarter of 2009 primarily due to higher volume and cost reduction initiatives.

Health & Science Technologies

• Sales in the second quarter of $100 million reflected a 36 percent increase compared to the second quarter of 2009 (+26 percent organic, +11 percent acquisition, and -1 percent for foreign currency translation).

• Operating margin of 20.7 percent represented a 500 basis point improvement compared with the second quarter of 2009 primarily due to higher volume and cost reduction initiatives.

Dispensing Equipment

• Sales in the second quarter of $41 million reflected a 10 percent decrease compared to the second quarter of 2009 (-8 percent organic and -2 percent for foreign currency translation).

• Operating margin of 23.6 percent represented a 170 basis point improvement compared with the second quarter of 2009 primarily due to cost reduction initiatives and productivity improvements.

Fire & Safety/Diversified Products

• Sales in the second quarter of $64 million reflected a 3 percent increase compared to the second quarter of 2009 (+5 percent organic and -2 percent for foreign currency translation).

• Operating margin of 21.9 percent represented a 20 basis point decline compared with the second quarter of 2009.

For the second quarter of 2010, Fluid & Metering Technologies contributed 46 percent of sales and 41 percent of operating income; Health & Science Technologies accounted for 26 percent of sales and 27 percent of operating income; Dispensing Equipment accounted for 11 percent of sales and 13 percent of operating income; and Fire & Safety/Diversified Products represented 17 percent of sales and 19 percent of operating income.

Conference Call to be Broadcast over the Internet

IDEX will broadcast its second quarter earnings conference call over the Internet on Tuesday, July 20, 2010 at 9:30 a.m. CT. Chairman and Chief Executive Officer Larry Kingsley and Vice President and Chief Financial Officer Dominic Romeo will discuss the company’s recent financial performance and respond to questions from the financial analyst community. IDEX invites interested investors to listen to the call and view the accompanying slide presentation, which will be carried live on its website at www.idexcorp.com. Those who wish to participate should log on several minutes before the discussion begins. After clicking on the presentation icon, investors should follow the instructions to ensure their systems are set up to hear the event and view the presentation slides, or download the correct applications at no charge. Investors will also be able to hear a replay of the call by dialing 800.642.1687 (or 706.645.9291 for international participants) using the ID # 81612030.

A Note on EBITDA and Free Cash Flow

EBITDA means earnings before interest, income taxes, depreciation and amortization, while free cash flow means cash flow from operating activities less capital expenditures plus the excess tax benefit from stock-based compensation. Management uses these non-GAAP financial measures as internal operating metrics and for enterprise valuation purposes. Management believes these measures are useful as analytical indicators of leverage capacity and debt servicing ability, and uses them to measure financial performance as well as for planning purposes. However, they should not be considered as alternatives to net income, cash flow from operating activities or any other items calculated in accordance with U.S. GAAP, or as an indicator of operating performance. The definitions of EBITDA and free cash flow used here may differ from those used by other companies.

EBITDA and Free Cash Flow bridge

	For the Quarter Ended
	June 30,									March 31,
	2010			2009			Change			2010			Change
® Income before Taxes	$	59.4		$	41.9			42	%	$	54.7			9	%
® Depreciation and Amortization		15.4			14.2			9			14.3			8
® Interest		3.6			4.4			(19	)		3.4			5
® EBITDA	$	78.4		$	60.5			30		$	72.4			8
® Cash Flow from Operating Activities	$	68.6		$	55.3			24	%	$	27.1			n/m	%
® Capital Expenditures		(10.0	)		(6.1	)		63			(7.5	)		32
® Excess Tax Benefit from Stock-Based Compensation		1.7			0.6			n/m			0.5			n/m
® Free Cash Flow	$	60.3		$	49.8			21		$	20.1			n/m

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934, as amended. These statements may relate to, among other things, capital expenditures, cost reductions, cash flow, and operating improvements and are indicated by words or phrases such as “anticipate,” “estimate,” “plans,” “expects,” “projects,” “should,” “will,” “management believes,” “the company believes,” “the company intends,” and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this news release. The risks and uncertainties include, but are not limited to, the following: economic and political consequences resulting from terrorist attacks and wars; levels of industrial activity and economic conditions in the U.S. and other countries around the world; pricing pressures and other competitive factors, and levels of capital spending in certain industries – all of which could have a material impact on order rates and IDEX’s results, particularly in light of the low levels of order backlogs it typically maintains; its ability to make acquisitions and to integrate and operate acquired businesses on a profitable basis; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which the company operates; interest rates; capacity utilization and the effect this has on costs; labor markets; market conditions and material costs; and developments with respect to contingencies, such as litigation and environmental matters. The forward-looking statements included here are only made as of the date of this news release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.

About IDEX

IDEX Corporation is an applied solutions company specializing in fluid and metering technologies, health and science technologies, dispensing equipment, and fire, safety and other diversified products built to its customers’ exacting specifications. Its products are sold in niche markets to a wide range of industries throughout the world. IDEX shares are traded on the New York Stock Exchange and Chicago Stock Exchange under the symbol “IEX”.

For further information on IDEX Corporation and its business units, visit the company’s Web site at www.idexcorp.com.
(Tables follow)

IDEX CORPORATION

IDEX CORPORATION
Condensed Statements of Consolidated Operations
(in thousands except per share amounts)

	Three Months Ended					Six Months Ended
	June 30,					June 30,
	2010		2009			2010		2009
Net sales	$	378,526	$	336,455		$	734,124	$	663,068
Cost of sales		223,705		205,354			431,762		408,773
Gross profit		154,821		131,101			302,362		254,295
Selling, general and administrative expenses		91,010		81,116			178,791		162,898
Restructuring expenses		1,031		3,250			2,898		5,501
Operating income		62,780		46,735			120,673		85,896
Other income (expense) — net		239		(385	)		493		(576	)
Interest expense		3,599		4,440			7,033		9,261
Income before income taxes		59,420		41,910			114,133		76,059
Provision for income taxes		19,022		13,988			37,110		25,532
Net income	$	40,398	$	27,922		$	77,023	$	50,527
Earnings per Common Share:
Basic earnings per common share (a)	$	0.50	$	0.35		$	0.95	$	0.63
Diluted earnings per common share (a)	$	0.49	$	0.34		$	0.94	$	0.62
Share Data:
Basic weighted average common shares outstanding		80,369		79,675			80,225		79,594
Diluted weighted average common shares outstanding		81,800		80,507			81,655		80,363

Condensed Consolidated Balance Sheets
(in thousands )

	June 30,		December 31,
	2010		2009
Assets
Current assets
Cash and cash equivalents	$	159,138	$	73,526
Receivables — net		200,430		183,178
Inventories		170,109		159,463
Other current assets		47,773		35,545
Total current assets		577,450		451,712
Property, plant and equipment — net		179,284		178,283
Goodwill and intangible assets		1,447,072		1,461,799
Other noncurrent assets		7,721		6,363
Total assets	$	2,211,527	$	2,098,157
Liabilities and shareholders’ equity
Current liabilities
Trade accounts payable	$	83,204	$	73,020
Accrued expenses		131,549		98,730
Short-term borrowings		10,559		8,346
Dividends payable		12,223		9,586
Total current liabilities		237,535		189,682
Long-term borrowings		459,832		391,754
Other noncurrent liabilities		242,025		248,617
Total liabilities		939,392		830,053
Shareholders’ equity		1,272,135		1,268,104
Total liabilities and shareholders’ equity	$	2,211,527	$	2,098,157

-more-

IDEX CORPORATION

IDEX CORPORATION
Company and Business Group Financial Information
(dollars in thousands)

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2010(b)			2009			2010(b)			2009
Fluid & Metering Technologies
Net sales	$	174,548		$	157,000		$	347,425		$	314,018
Operating income (c)		30,779			24,221			63,289			47,939
Operating margin		17.6	%		15.4	%		18.2	%		15.3	%
Depreciation and amortization	$	8,203		$	8,566		$	16,225		$	16,335
Capital expenditures		6,063			3,315			9,671			5,872
Health & Science Technologies
Net sales	$	100,486		$	73,816		$	188,008		$	148,004
Operating income (c)		20,773			11,603			39,888			22,301
Operating margin		20.7	%		15.7	%		21.2	%		15.1	%
Depreciation and amortization	$	4,364		$	3,200		$	7,879		$	6,713
Capital expenditures		2,300			652			3,764			1,914
Dispensing Equipment
Net sales	$	41,135		$	45,658		$	74,689		$	78,531
Operating income (c)		9,716			10,021			16,470			14,070
Operating margin		23.6	%		21.9	%		22.1	%		17.9	%
Depreciation and amortization	$	1,131		$	886		$	2,164		$	1,670
Capital expenditures		429			340			642			558
Fire & Safety/Diversified Products
Net sales	$	63,991		$	62,127		$	127,392		$	127,109
Operating income (c)		14,041			13,736			27,464			27,330
Operating margin		21.9	%		22.1	%		21.6	%		21.5	%
Depreciation and amortization	$	1,346		$	1,248		$	2,798		$	2,528
Capital expenditures		1,012			894			1,876			1,716
Company
Net sales	$	378,526		$	336,455		$	734,124		$	663,068
Operating income (d)		63,811			49,985			123,571			91,397
Operating margin		16.9	%		14.9	%		16.8	%		13.8	%
Depreciation and amortization (e)	$	15,369		$	14,164		$	29,653		$	27,758
Capital expenditures		10,686			6,070			18,036			11,222

(a)	Calculated by applying the two-class method of allocating earnings to common stock and participating securities as required by ASC 260, Earnings Per Share.
(b)	Three and six month data includes acquisition of Seals (April 2010) in the Health & Science Technologies Group from the date of acquisition.
(c)	Group operating income excludes unallocated corporate operating expenses and restructuring-related charges.
(d)	Company operating income excludes restructuring-related charges.
(e)	Excludes amortization of debt issuance expenses.